AngioDynamics Inc at KeyBanc Capital Markets Life Sciences & MedTech Forum (Virtual) Transcript
Hey, good afternoon. I'd like to welcome everyone to the last meeting of the first day of the KeyBanc Life Sciences & MedTech Investor Forum. My name is Matt Mishan; I'm a senior medtech analyst. And I'm pleased to be joined by AngioDynamics, which is represented today by its CEO, Jim Clemmer; and CFO, Steve Trowbridge.
For the audience, I'll start this off, but questions can be submitted directly to me by typing into the box below the video stream, and I can relay. With that, I'll open it up with you guys.
Questions & Answers
You are reporting earnings in a couple of weeks, and I will wait for more detail then, but just -- could you just briefly describe how procedural trends have progressed over the past several months?
Sure. And thanks, Matt, for KeyBanc sponsoring an excellent conference today. Thanks for the invitation to your conference.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
